Table 5: The correlation between the change of second-phase insulin secretion before and after treatment (δ-SPIS) with various factors
a | Partial correlation coefficient | p value |
| Age | -0.5963 | 0.001 |
| Body mass index (kg/m2) | -0.4045 | 0.045 |
| Waist circumference (cm) | -0.4385 | 0.028 |
| Hip circumference (cm) | -0.3549 | 0.082 |
| Waist-hip ratio | -0.1857 | 0.374 |
| Systolic blood pressure (mmHg) | 0.0835 | 0.691 |
| Diastolic blood pressure (mmHg) | 0.0310 | 0.883 |
| Fasting plasma glucose (mg/dl) | 0.2564 | 0.216 |
| Fasting plasma insulin (pmol/l) | -0.2074 | 0.320 |
| Hemoglobin A1c (%) | 0.5288 | 0.008 |
| δA1C | -0.4967 | 0.043 |
| Total Cholesterol (mmol/l) | -0.2025 | 0.332 |
| Triglyceride (mmol/l) | 0.5494 | 0.004 |
| HDL-C (mmol/l) | 0.0729 | 0.729 |
| First-phase insulin secretionb | -0.1158 | 0.582 |
| Second-phase insulin secretionc | -0.4040 | 0.045 |
| Insulin sensitivity | -0.1509 | 0.472 |
| Glucose effectiveness | 0.1627 | 0.437 |
| HOMA-IR | 0.0442 | 0.834 |
| HOMA-B | -0.3660 | 0.072 |